167 related articles for article (PubMed ID: 28822348)
1. Risk factors for potential drug-drug interactions in intensive care unit patients.
Janković SM; Pejčić AV; Milosavljević MN; Opančina VD; Pešić NV; Nedeljković TT; Babić GM
J Crit Care; 2018 Feb; 43():1-6. PubMed ID: 28822348
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
[TBL] [Abstract][Full Text] [Related]
3. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
Moura C; Prado N; Acurcio F
Clin Drug Investig; 2011; 31(5):309-16. PubMed ID: 21344954
[TBL] [Abstract][Full Text] [Related]
4. [Drug-drug interactions in intensive care patients].
Saaby L; Olesen C; Fedder J; Haunstrup E
Ugeskr Laeger; 2009 Sep; 171(39):2817-22. PubMed ID: 19811752
[TBL] [Abstract][Full Text] [Related]
5. Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved.
Smithburger PL; Kane-Gill SL; Seybert AL
Int J Pharm Pract; 2012 Dec; 20(6):402-8. PubMed ID: 23134100
[TBL] [Abstract][Full Text] [Related]
6. Potential drug-drug interactions in a medical intensive care unit of a university hospital.
Gülçebi İdriz Oğlu M; Küçükibrahimoğlu E; Karaalp A; Sarikaya Ö; Demirkapu M; Onat F; Gören MZ
Turk J Med Sci; 2016 Apr; 46(3):812-9. PubMed ID: 27513261
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of potential drug - drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital.
Wang H; Shi H; Wang N; Wang Y; Zhang L; Zhao Y; Xie J
BMC Pharmacol Toxicol; 2022 Jun; 23(1):39. PubMed ID: 35701808
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.
Ismail M; Khan F; Noor S; Haider I; Haq IU; Ali Z; Shah Z; Hassam M
Int J Clin Pharm; 2016 Oct; 38(5):1052-6. PubMed ID: 27365090
[TBL] [Abstract][Full Text] [Related]
10. Potential drug-drug interactions in acute poisonings managed in the intensive care unit: Occurrence, risk factors and relationship to patient severity on admission.
Mainoli B; Gonçalves N; Ferreira JJ; Mégarbane B
Basic Clin Pharmacol Toxicol; 2022 Feb; 130(2):337-345. PubMed ID: 34873835
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic drug-drug interactions in the intensive care unit - single-centre experience and literature review.
Łój P; Olender A; Ślęzak W; Krzych ŁJ
Anaesthesiol Intensive Ther; 2017; 49(4):259-267. PubMed ID: 29027654
[TBL] [Abstract][Full Text] [Related]
12. Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study.
Bakker T; Klopotowska JE; de Keizer NF; van Marum R; van der Sijs H; de Lange DW; de Jonge E; Abu-Hanna A; Dongelmans DA;
J Crit Care; 2020 Jun; 57():134-140. PubMed ID: 32145656
[TBL] [Abstract][Full Text] [Related]
13. Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.
Khan Q; Ismail M; Khan S
BMC Pharmacol Toxicol; 2017 Dec; 18(1):75. PubMed ID: 29191244
[TBL] [Abstract][Full Text] [Related]
14. Incidence of drug interactions in intensive care units in tertiary care settings: Classification, facts and measures.
Hasnain H; Ali H; Zafar F; Sial AA; Alam S; Beg AE; Bushra R; Rizvi M; Khan MA; Shareef H; Naqvi GR; Tariq A
Pak J Pharm Sci; 2018 Mar; 31(2(Suppl.)):669-675. PubMed ID: 29625940
[TBL] [Abstract][Full Text] [Related]
15. The effect of the TIM program (Transfer ICU Medication reconciliation) on medication transfer errors in two Dutch intensive care units: design of a prospective 8-month observational study with a before and after period.
Bosma BE; Meuwese E; Tan SS; van Bommel J; Melief PH; Hunfeld NG; van den Bemt PM
BMC Health Serv Res; 2017 Feb; 17(1):124. PubMed ID: 28183302
[TBL] [Abstract][Full Text] [Related]
16. Drug-drug interactions in patients with acute coronary syndrome across phases of treatment.
Pejčić AV; Janković SM; Davidović G
Intern Emerg Med; 2019 Apr; 14(3):411-422. PubMed ID: 30483990
[TBL] [Abstract][Full Text] [Related]
17. Impact of pharmacists' intervention on identification and management of drug-drug interactions in an intensive care setting.
Hasan SS; Lim KN; Anwar M; Sathvik BS; Ahmadi K; Yuan AW; Kamarunnesa MA
Singapore Med J; 2012 Aug; 53(8):526-31. PubMed ID: 22941130
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for mortality following interhospital transfers to the medical intensive care unit of a tertiary referral center.
Durairaj L; Will JG; Torner JC; Doebbeling BN
Crit Care Med; 2003 Jul; 31(7):1981-6. PubMed ID: 12847392
[TBL] [Abstract][Full Text] [Related]
19. Potential drug-drug interactions when managing status epilepticus patients in intensive care: A cohort study.
Le Roux C; Destère A; Hervy S; Lloret-Linares C; Reignier J; Caillet P; Jolliet P; Mégarbane B; Boels D
Br J Clin Pharmacol; 2022 May; 88(5):2408-2418. PubMed ID: 34907586
[TBL] [Abstract][Full Text] [Related]
20. The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients.
Rosas-Carrasco O; García-Peña C; Sánchez-García S; Vargas-Alarcón G; Gutiérrez-Robledo LM; Juárez-Cedillo T
Rev Invest Clin; 2011; 63(6):564-73. PubMed ID: 23650669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
